Epilepsy affects 50 million people worldwide. 12 million strokes occur annually. Both conditions significantly impact individuals and healthcare systems.
Stroke and cerebrovascular diseases are the leading causes of seizures and epilepsy in adults, providing a valuable opportunity to study the processes underlying epilepsy development.
Epilepsy after stroke typically emerges following a silent period lasting months to years, providing a window of opportunity for preventive treatments.
We harness collaboration between leading international experts to study the processes underlying post-stroke epilepsy and provide practical tools for clinicians and patients.
We provide several models to calculate the risk of epilepsy after ischemic stroke. They are implemented in practical web and smartphone application.
We are committed to supporting evidence-based decision-making through statistical models. To facilitate their use in clinical practice, we have gathered the most widely used models for predicting epilepsy risk on a single platform.
The SeLECT Consortium is conducting several ongoing multicenter research projects focused on the risk of post-stroke epilepsy and antiepileptogenesis. Consortium members can participate in these projects and access detailed project outlines through a password-protected site.
We encourage consortium members and the broader research community to submit new project proposals utilizing SeLECT Consortium data. To submit a proposal, please complete the project proposal form and contact us.
From the original SeLECT score (2018) to continuous-EEG prediction (2025), each study built on the last — adding seizure type, driving guidance, EEG biomarkers and more. Follow the timeline, then explore each paper below.
Scroll through the covers · click a card for the abstract, key points and graphical abstract.
24 partner institutions powering the SeLECT multicentre network.
